- Home
- CTS vs KOD Comparison
CTS vs KOD Comparison
Compare CTS & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTS | KOD |
|---|---|---|
| Founded | 1896 | 2009 |
| Country | United States | United States |
| Employees | N/A | 121 |
| Industry | Electrical Products | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.5B |
| IPO Year | 1994 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CTS | KOD |
|---|---|---|
| Price | $45.79 | $23.19 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $28.29 |
| AVG Volume (30 Days) | 202.0K | ★ 503.1K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.34% | N/A |
| EPS Growth | 15.87 | ★ 32.60 |
| EPS | ★ 2.19 | N/A |
| Revenue | ★ $541,318,000.00 | N/A |
| Revenue This Year | $5.55 | N/A |
| Revenue Next Year | $5.00 | N/A |
| P/E Ratio | $21.37 | ★ N/A |
| Revenue Growth | ★ 4.95 | N/A |
| 52 Week Low | $34.02 | $1.92 |
| 52 Week High | $59.66 | $31.18 |
Technical Indicators
Market Signals| Indicator | CTS | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 29.34 | 41.55 |
| Support Level | $40.41 | $21.19 |
| Resistance Level | $59.66 | $29.17 |
| Average True Range (ATR) | 1.62 | 1.70 |
| MACD | -0.86 | -0.35 |
| Stochastic Oscillator | 3.90 | 8.59 |
Price Performance
Historical ComparisonAbout CTS CTS Corporation
CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEMs) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China, Singapore, the Czech Republic, Taiwan, Denmark, and other countries.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.